Astrid Schwantes
Overview
Explore the profile of Astrid Schwantes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
304
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Reitz S, Schwantes A
PDA J Pharm Sci Technol
. 2021 Dec;
76(4):297-305.
PMID: 34911829
Session 1 of the 2019 Viral Clearance Symposium proposed strategies to use prior knowledge for demonstrating robust viral clearance for biotechnologically produced recombinant proteins, such as monoclonal antibodies, and introduced...
2.
Specht R, Schwantes A
PDA J Pharm Sci Technol
. 2021 Dec;
76(4):306-314.
PMID: 34911828
In Session 2 of the 2019 Viral Clearance Symposium, new outcomes of viral clearance performance of polishing chromatography and depth filters utilized in the purification processes of biotechnologically produced recombinant...
3.
Blumel J, Schwantes A, Baylis S, Stuhler A
Transfusion
. 2020 Jan;
60(1):219-220.
PMID: 31898348
No abstract available.
4.
Schwantes A, Specht R, Chen Q
PDA J Pharm Sci Technol
. 2018 Jul;
72(5):498-510.
PMID: 30030357
Appropriate performance of virus validation studies and testing of unprocessed bulk harvests for retrovirus particle count are procedures in the demonstration of an acceptable level of viral safety for cell-derived...
5.
Zimmerling S, Waibler Z, Resch T, Sutter G, Schwantes A
Virol J
. 2013 Jan;
10:34.
PMID: 23356675
Background: Modified vaccinia virus Ankara (MVA) is a highly attenuated virus and a promising vaccine vector with potent immune stimulating properties. Deletion of the gene encoding the viral interleukin-1beta receptor...
6.
Wenzel M, Wunderlich M, Besch R, Poeck H, Willms S, Schwantes A, et al.
J Immunol
. 2011 Dec;
188(1):394-403.
PMID: 22140256
A key host response to limit microbial spread is the induction of cell death when foreign nucleic acids are sensed within infected cells. In mouse macrophages, transfected DNA or infection...
7.
Gratz M, Suezer Y, Kremer M, Volz A, Majzoub M, Hanschmann K, et al.
J Virol
. 2011 Jan;
85(7):3557-69.
PMID: 21270149
The emergence of zoonotic orthopoxvirus infections and the threat of possible intentional release of pathogenic orthopoxviruses have stimulated renewed interest in understanding orthopoxvirus infections and the resulting diseases. Ectromelia virus...
8.
Kreijtz J, Suzer Y, Bodewes R, Schwantes A, van Amerongen G, Verburgh R, et al.
J Gen Virol
. 2010 Aug;
91(Pt 11):2745-52.
PMID: 20719991
The zoonotic transmissions of highly pathogenic avian influenza viruses of the H5N1 subtype that have occurred since 1997 have sparked the development of novel influenza vaccines. The advent of reverse...
9.
Zwilling J, Sliva K, Schwantes A, Schnierle B, Sutter G
Virology
. 2010 Jul;
404(2):231-9.
PMID: 20627347
Modified vaccinia virus Ankara (MVA) was generated by serial passaging in chicken embryo fibroblasts. During this attenuation, MVA lost the capacity to productively grow in human and most other mammalian...
10.
Kreijtz J, Suezer Y, de Mutsert G, van Amerongen G, Schwantes A, van den Brand J, et al.
PLoS One
. 2009 Nov;
4(11):e7790.
PMID: 19915662
Human infections with highly pathogenic avian influenza viruses of the H5N1 subtype, frequently reported since 2003, result in high morbidity and mortality. It is feared that these viruses become pandemic,...